Corteva Inc
NYSE:CTVA
Intrinsic Value
The intrinsic value of one
CTVA
stock under the Base Case scenario is
63.78
USD.
Compared to the current market price of 56.84 USD,
Corteva Inc
is
Undervalued by 11%.
The Intrinsic Value is calculated as the average of the two valuation methods:
Fundamental Analysis
CTVA Profitability Score
Profitability Due Diligence
Corteva Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
Corteva Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
CTVA Solvency Score
Solvency Due Diligence
Corteva Inc's solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Score
Corteva Inc's solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Balance Sheet Decomposition
Corteva Inc
| Current Assets | 16.8B |
| Cash & Short-Term Investments | 3.3B |
| Receivables | 5.7B |
| Other Current Assets | 7.8B |
| Non-Current Assets | 25.8B |
| Long-Term Investments | 102M |
| PP&E | 4.3B |
| Intangibles | 19.3B |
| Other Non-Current Assets | 2.2B |
| Current Liabilities | 10.7B |
| Accounts Payable | 4.9B |
| Accrued Liabilities | 2.3B |
| Short-Term Debt | 23M |
| Other Current Liabilities | 3.6B |
| Non-Current Liabilities | 6.6B |
| Long-Term Debt | 1.3B |
| Other Non-Current Liabilities | 5.3B |
CTVA Capital Structure
Corteva Inc
| Market Capitalization | 40.6B USD | |
| Total Debt | 1.3B USD | |
| Minority Interest | 239M USD | |
| Preferred Equity | 0 USD | |
| Cash and Equivalents | 3.2B USD | |
| Short-Term Investments | 124M USD | |
| Enterprise Value | 38.8B USD | |
Wall St
Price Targets
CTVA Price Targets Summary
Corteva Inc
According to Wall Street analysts, the average 1-year price target for
CTVA
is 74.16 USD
with a low forecast of 60.6 USD and a high forecast of 91.35 USD.
Ownership
CTVA Insider Trading
Buy and sell transactions by insiders
During the last 12 months Corteva Inc insiders bought 2.4M USD , and have not sold any shares. The last transaction was made on Mar 25, 2023 by Magro Charles V. (Chief Executive Officer), who bought 2.4M USD worth of CTVA shares.
| Period | Sold | Bought | Net |
|---|---|---|---|
| 3 Months |
N/A
|
2.4M
USD
|
2.4M
|
| 6 Months |
N/A
|
2.4M
USD
|
2.4M
|
| 9 Months |
N/A
|
2.4M
USD
|
2.4M
|
| 12 Months |
N/A
|
2.4M
USD
|
2.4M
|
Shareholder Return
CTVA Return Decomposition
Main factors of price return
Market capitalization of
CTVA
shares
increased
by
105.28%
over the past 5 years.
The primary factor behind the change was
an increase
in P/E multiple from
10.3
to
35.4, leading to a
growth
in the market capitalization of Corteva Inc by 181.22%.
Market capitalization of
CTVA
shares
increased
by
105.28%
over the past 5 years.
The primary factor behind the change was
an increase
in P/E multiple from
10.3
to
35.4, leading to a
growth
in the market capitalization of Corteva Inc by 181.22%.
CTVA Price
Corteva Inc
| Average Annual Return | 19.93% |
| Standard Deviation of Annual Returns | 18.29% |
| Max Drawdown | -34% |
| Market Capitalization | 40.6B USD |
| Shares Outstanding | 714 700 000 |
| Percentage of Shares Shorted | 1.15% |
Company Profile
Corteva Inc
Country
Industry
Market Cap
Dividend Yield
Description
Corteva, Inc. is a global provider of seed and crop protection solutions focused on the agriculture industry and contributing to food supply. The company is headquartered in Indianapolis, Indiana and currently employs 21,000 full-time employees. The company went IPO on 2019-05-24. Its seed segment is engaged in developing and supplying germplasm and traits that produce optimum yields for farms around the world. This segment offers trait technologies that improve resistance to weather, disease, insects and herbicides used to control weeds, and trait technologies that enhance food and nutritional characteristics, and provides digital solutions that assist farmers in decision-making. Its crop protection segment serves the global agricultural input industry with products that protect against weeds, insects and other pests, and disease, and that improve overall crop health both above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers and pasture and range management herbicides. Its portfolio of brands includes CLOSER, DELEGATE, Pioneer, Brevant seeds and others.
Contact
IPO
Employees
Officers
The intrinsic value of one
CTVA
stock under the Base Case scenario is
63.78
USD.
Compared to the current market price of 56.84 USD,
Corteva Inc
is
Undervalued by 11%.
